You are about to be taken to a third-party site. The content on this site is for informational use only. Immunocine does not endorse any of the information, products, or services on third-party sites, and no information on third-party sites should be construed as an endorsement or recommendation of specific Immunocine products. By clicking on the link below, you consent to be directed to external material.Proceed Cancel
While Immunocine prides itself on the amount of dedicated research behind our unique Immunotherapy, ultimately the treatment results are what matter. With over 20+ different types of cancer treated from a variety cancer stages, Immunocine has seen remarkable successes with late stage cancer patients.
In 2021, Kareema was diagnosed with Stage 4 Neuroendocrine Cancer. Relying on Lanreotide and alternative cancer treatments such diet changes, Kareema was able to temporarily slow her cancer’s progression. Unfortunately, her cancer continued to progress in 2022, and Kareema’s oncologists believed her cancer was now terminal.
For the first time since 2022, Kareema is now seeing a treatment that is working. By October, her Chromagranin-A cancer markers fell into normal levels. In November, a CT Scan performed by her US physicians already detected some of her tumors dissipating.
In 2014, Chris was diagnosed with Stage 4 Prostate Cancer and immediately started Chemotherapy. By 2017, Chris was in need of a different treatment option. His cancer had spread to 30 different locations throughout his body. In addition, Chemotherapy had nearly killed him as well.
After reading the early research of Immunocine’s treatment, Chris traveled to Houston to meet with the research team. With two kids that were six and eight years old, Chris was willing to do whatever it took to beat his cancer.
After receiving an earlier version of Immunocine’s Dendritic Cell Treatment, Chris has seen his PSA level go from 212 to 0. His 30 tumors were destroyed, and Chris remains in remission to this day.
First diagnosed with Breast Cancer in 2012, Sheryl thought she had achieved remission after receiving Chemotherapy and Radiation. In 2022, Sheryl's cancer relapsed and she was diagnosed with Stage 4 Breast Cancer with metastases to her femur. Not content with a prognosis of 18 months, Sheryl began looking for alternative cancer treatment centers.
After extensive research into the latest developments in Cancer Research, Sheryl and her daughter decided to pursue Immunocine's Cancer Immunotherapy. Receiving treatment in April 2022, Sheryl felt her Immune System attacking her once unresponsive tumor in her femur. By August 2022, her physicians in Canada confirmed that the tumor in her femur had been eliminated.
In 2020, Lynn was diagnosed with Stage 4 Triple Negative Breast Cancer. Despite receiving several treatments of Chemotherapy and Radiation, Lynn's cancer was unfortunately progressing and had metastasized into her lungs.
With rapidly rising cancer markers, Lynn began searching for alternative treatments and ultimately discovered Immunocine. With her background in healthcare and a family full of healthcare professionals, Lynn and her family began reviewing the research behind Immunocine's protocol with a healthy skepticism. However, after numerous meetings with her and the Immunocine Team, Lynn ultimately chose to pursue treatment in August 2022.
Upon completing treatment, Lynn's rapidly growing cancer markers stabilized and began decreasing. In addition, each tumor has demonstrated T cell infiltration corresponding to the body actively fighting her previously unresponsive cancer.
"After my mother's Chemotherapy and hormone therapy stopped working, we were told by her doctors in the US that there was nothing more they could do for her. I was lucky enough to find the Immunocine team and they welcomed my mom into treatment.
We spent a month going back and forth to Cancun for her treatment and I am happy to report that her immune system is fighting! We are 1 year out from when we first came to Immunocine for help. At that time, my mom was in rapid decline. Today my mom's bloodwork is looking more stable and her hemoglobin has increased.
The love and care that she has been given by this team, even after the treatment was over, is unmatched and I am so grateful to have them in our lives and part of her care team."
"My mother was first diagnosed with stage 2 HER+ breast cancer in 2012, and treated at our local cancer clinic in Edmonton, Alberta Canada where she received the typical surgery, chemotherapy, radiation and hormone therapy. In February 2022, her cancer recurred in her femur and my mom was diagnosed with stage 4 HER+ metastatic breast cancer.
After reviewing their literature, we had a second meeting with Dr. Alberto Ortiz who was my mother's primary medical doctor throughout the treatment process (along with the oncologist, hematologist, and radiologist). In this hour and a half meeting, Dr. Ortiz explained about how each step in the treatment process was to be completed, what each step would feel like for my mother, and discussed all possible side effects of the treatment and how they would monitor her progress and be with us every step of the way.
We are all optimistic based on my mother’s progress thus far that she will be another patient who lives for many years in durable remission with no evidence of disease. And since we cannot predict the future and everyone is different and I know results can vary, personal experience and objective evidence allow me to sleep at night knowing we definitely picked a professional and genuine group and a real strong scientific option to give my mother the best shot possible."